{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:39:25Z","timestamp":1790170765455,"version":"4.1.0"},"reference-count":142,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2015.00258","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T13:11:09Z","timestamp":1433250669000},"source":"Crossref","is-referenced-by-count":24,"title":["Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?"],"prefix":"10.3389","volume":"6","author":[{"given":"Marian","family":"Nassef Kadry Naguib Roufaiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Steptoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"Kuppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"B2","author":"National Cancer Institute Non-Hodgkin Lymphoma"},{"key":"B3","author":"National Cancer Institute","journal-title":"A Snapshot of Lymphoma"},{"key":"B4","first-page":"241","article-title":"Depressed immunity and the development of cancer","volume":"18","author":"Penn","year":"1994","journal-title":"Cancer Detect Prev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/s1567-5769(03)00060-2","article-title":"Immunodeficiency and cancer: prospects for correction","volume":"3","author":"Hadden","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nrclinonc.2012.111","article-title":"T-cell therapy in the treatment of post-transplant lymphoproliferative disease","volume":"9","author":"Bollard","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/bjc.1986.31","article-title":"Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin\u00e2\u20ac\u2122s lymphoma","volume":"53","author":"Guy","year":"1986","journal-title":"Br J Cancer"},{"key":"B9","first-page":"411","article-title":"The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression","volume":"59","author":"Moller","year":"1986","journal-title":"Immunology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.2399","article-title":"Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways","volume":"216","author":"Booman","year":"2008","journal-title":"J Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","article-title":"Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project","volume":"103","author":"Rimsza","year":"2004","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.can-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1084\/jem.20050715","article-title":"Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma","volume":"202","author":"Rodriguez","year":"2005","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/ijc.24014","article-title":"Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses","volume":"124","author":"Moormann","year":"2009","journal-title":"Int J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2006-04-015164","article-title":"Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients","volume":"108","author":"Gandhi","year":"2006","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e1122","DOI":"10.1371\/journal.pone.0001122","article-title":"Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy","volume":"2","author":"Li","year":"2007","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1073\/pnas.0813320106","article-title":"Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"106","author":"Fogg","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493","article-title":"Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBVpositive Hodgkin\u00e2\u20ac\u2122s disease","volume":"86","author":"Frisan","year":"1995","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-03-3066","article-title":"Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance","volume":"64","author":"Zippelius","year":"2004","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.4049\/jimmunol.175.9.6169","article-title":"Tumor progression can occur despite the induction of very high levels of self\/tumor antigen-specific CD8+ T cells in patients with melanoma","volume":"175","author":"Rosenberg","year":"2005","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1158\/0008-5472.can-11-2637","article-title":"CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1","volume":"72","author":"Fourcade","year":"2012","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1172\/jci46102","article-title":"Exhaustion of tumor-specific CD8(+) T cells in metastases from melanoma patients","volume":"121","author":"Baitsch","year":"2011","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.4049\/jimmunol.178.4.2094","article-title":"Cognate CD4+ help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8+ T cells","volume":"178","author":"Steptoe","year":"2007","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"Bonifaz","year":"2002","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/1074-7613(95)90009-8","article-title":"In the absence of a CD40 signal, B cells are tolerogenic","volume":"2","author":"Buhlmann","year":"1995","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1084\/jem.187.10.1611","article-title":"Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo","volume":"187","author":"Townsend","year":"1998","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.4049\/jimmunol.151.6.2958","article-title":"Parameters of tolerance induction by antigen targeted to B lymphocytes","volume":"151","author":"Eynon","year":"1993","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.188.11.1977","article-title":"B cells directly tolerize CD8(+) T cells","volume":"188","author":"Bennett","year":"1998","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.4049\/jimmunol.178.12.7738","article-title":"Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance","volume":"178","author":"Werner-Klein","year":"2007","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.4049\/jimmunol.181.5.3221","article-title":"Anergy in memory CD4+ T cells is induced by B cells","volume":"181","author":"Dalai","year":"2008","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4049\/jimmunol.0900032","article-title":"Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function","volume":"184","author":"Kenna","year":"2010","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1182\/blood-2011-02-336115","article-title":"Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion","volume":"118","author":"Morlacchi","year":"2011","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/eji.201344062","article-title":"TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance","volume":"44","author":"Lee","year":"2014","journal-title":"Eur J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2015.02.004","article-title":"B-Cells induce regulatory T cells through TGF-beta\/IDO production in A CTLA-4 dependent manner","volume":"59","author":"Nouel","year":"2015","journal-title":"J Autoimmun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/imr.12176","article-title":"B10 cell regulation of health and disease","volume":"259","author":"Candando","year":"2014","journal-title":"Immunol Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"701704","DOI":"10.1155\/2012\/701704","article-title":"Murine models of B-Cell lymphomas: promising tools for designing cancer therapies","volume":"2012","author":"Donnou","year":"2012","journal-title":"Adv Hematol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1073\/pnas.95.3.1178","article-title":"Induction of antigen-specific T cell anergy: an early event in the course of tumor progression","volume":"95","author":"Staveley-O\u00e2\u20ac\u2122Carroll","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1182\/blood-2005-07-3014","article-title":"In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity","volume":"107","author":"Horna","year":"2006","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1182\/blood.V98.4.1070","article-title":"Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression","volume":"98","author":"Sotomayor","year":"2001","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/icb.2010.131","article-title":"Induction of antigen-specific effector-phase tolerance following vaccination against a previously ignored B-cell lymphoma","volume":"89","author":"Prato","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e34552","DOI":"10.1371\/journal.pone.0034552","article-title":"Stromal interferon-\u00ce\u00b3 signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice","volume":"7","author":"Gerbitz","year":"2012","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.4049\/jimmunol.1300803","article-title":"Rapid deletion and inactivation of CTLs upon recognition of a number of target cells over a critical threshold","volume":"191","author":"Prato","year":"2013","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.smim.2005.09.002","article-title":"A dynamic view of the immunological synapse","volume":"17","author":"Dustin","year":"2005","journal-title":"Semin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-642-03858-7_5","article-title":"The immunological synapse, TCR microclusters, and T cell activation","volume":"340","author":"Yokosuka","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"a002311","DOI":"10.1101\/cshperspect.a002311","article-title":"Understanding the structure and function of the immunological synapse","volume":"2","author":"Dustin","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2567.2010.03366.x","article-title":"Diversity in immunological synapse structure","volume":"131","author":"Thauland","year":"2010","journal-title":"Immunology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.immuni.2006.04.010","article-title":"T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster","volume":"25","author":"Varma","year":"2006","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/25764","article-title":"Three-dimensional segregation of supramolecular activation clusters in T cells","volume":"395","author":"Monks","year":"1998","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.4049\/jimmunol.177.3.1721","article-title":"Filamin A is required for T cell activation mediated by protein kinase C-theta","volume":"177","author":"Hayashi","year":"2006","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.immuni.2008.08.011","article-title":"Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation","volume":"29","author":"Yokosuka","year":"2008","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/eji.200425857","article-title":"Multifocal structure of the T cell \u00e2\u20ac\u201c dendritic cell synapse","volume":"35","author":"Brossard","year":"2005","journal-title":"Eur J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1182\/blood-2008-04-149526","article-title":"Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T-cell clustering","volume":"112","author":"Fisher","year":"2008","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.4049\/jimmunol.181.7.4852","article-title":"T cell-dendritic cell immunological synapses contain TCR-dependent CD28-CD80 clusters that recruit protein kinase C theta","volume":"181","author":"Tseng","year":"2008","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1126\/science.285.5425.221","article-title":"The immunological synapse: a molecular machine controlling T cell activation","volume":"285","author":"Grakoui","year":"1999","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1034\/j.1600-065X.2002.18610.x","article-title":"The immunological synapse: integrins take the stage","volume":"186","author":"Sims","year":"2002","journal-title":"Immunol Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/341619a0","article-title":"T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1","volume":"341","author":"Dustin","year":"1989","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ceb.2011.10.004","article-title":"Integrin inside-out signaling and the immunological synapse","volume":"24","author":"Springer","year":"2012","journal-title":"Curr Opin Cell Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ni950","article-title":"RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1","volume":"4","author":"Katagiri","year":"2003","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-065X.2007.00537.x","article-title":"The role of the integrin LFA-1 in T-lymphocyte migration","volume":"218","author":"Smith","year":"2007","journal-title":"Immunol Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.4049\/jimmunol.179.3.1616","article-title":"LFA-1-mediated T cell costimulation through increased localization of TCR\/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse","volume":"179","author":"Graf","year":"2007","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0960-9822(00)00362-6","article-title":"Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes","volume":"10","author":"Leupin","year":"2000","journal-title":"Curr Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"12729","DOI":"10.1073\/pnas.0902621106","article-title":"Cluster size regulates protein sorting in the immunological synapse","volume":"106","author":"Hartman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ni1272","article-title":"Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76","volume":"6","author":"Yokosuka","year":"2005","journal-title":"Nat Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.immuni.2010.04.005","article-title":"Essential role of ubiquitin and TSG101 protein in formation and function of the central supramolecular activation cluster","volume":"32","author":"Vardhana","year":"2010","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1084\/jem.185.10.1859","article-title":"Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation","volume":"185","author":"Valitutti","year":"1997","journal-title":"J Exp Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-2567.2011.03458.x","article-title":"The immunological synapse: a cause or consequence of T-cell receptor triggering?","volume":"133","author":"Alarcon","year":"2011","journal-title":"Immunology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0952-7915(99)00075-8","article-title":"Genomic-scale analysis of gene expression in resting and activated T cells","volume":"12","author":"Marrack","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/bioinformatics\/bth093","article-title":"Modeling T-cell activation using gene expression profiling and state-space models","volume":"20","author":"Rangel","year":"2004","journal-title":"Bioinformatics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1182\/blood-2006-10-053793","article-title":"Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse","volume":"110","author":"Reichardt","year":"2007","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/ni713","article-title":"Functional antigen-independent synapses formed between T cells and dendritic cells","volume":"2","author":"Revy","year":"2001","journal-title":"Nat Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1084\/jem.188.8.1473","article-title":"Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells","volume":"188","author":"Delon","year":"1998","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.4049\/jimmunol.171.9.4479","article-title":"Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent","volume":"171","author":"Al-Alwan","year":"2003","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1182\/blood-2009-04-217687","article-title":"Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy","volume":"114","author":"Ramsay","year":"2009","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1172\/jci35017","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"J Clin Invest"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1172\/jci24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells","volume":"115","author":"Gorgun","year":"2005","journal-title":"J Clin Invest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1073\/pnas.0901166106","article-title":"E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction","volume":"106","author":"Gorgun","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1074-7613(02)00421-1","article-title":"In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern","volume":"17","author":"Blanchard","year":"2002","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.4049\/jimmunol.167.10.5708","article-title":"Superantigen-induced T cell:B cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70","volume":"167","author":"Morgan","year":"2001","journal-title":"J Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood-2009-02-206946","article-title":"Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts","volume":"114","author":"Le Dieu","year":"2009","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/jco.2012.44.2137","article-title":"Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation","volume":"31","author":"Kiaii","year":"2013","journal-title":"J Clin Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1200\/jco.2007.15.3429","article-title":"Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin\u00e2\u20ac\u2122s lymphoma","volume":"26","author":"Wiernik","year":"2008","journal-title":"J Clin Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1200\/jco.2008.21.1169","article-title":"Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin\u00e2\u20ac\u2122s Lymphoma","volume":"27","author":"Witzig","year":"2009","journal-title":"J Clin Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1093\/annonc\/mdt366","article-title":"Long-term follow-up of lenalidomide in relapsed\/refractory mantle cell lymphoma: subset analysis of the NHL-003 study","volume":"24","author":"Zinzani","year":"2013","journal-title":"Ann Oncol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/leu.2013.95","article-title":"Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial","volume":"27","author":"Wang","year":"2013","journal-title":"Leukemia"},{"key":"B93","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/cncr.28405","article-title":"Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas","volume":"120","author":"Ahmadi","year":"2014","journal-title":"Cancer"},{"key":"B94","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/s1470-2045(12)70200-0","article-title":"Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1\/2 clinical trial","volume":"13","author":"Wang","year":"2012","journal-title":"Lancet Oncol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e0119483","DOI":"10.1371\/journal.pone.0119483","article-title":"Blockade of PD-1\/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment","volume":"10","author":"Blake","year":"2015","journal-title":"PLoS One"},{"key":"B96","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1182\/blood-2006-12-062422","article-title":"Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells","volume":"110","author":"Goldberg","year":"2007","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.4049\/jimmunol.162.10.5813","article-title":"CTLA-4-mediated inhibition of early events of T cell proliferation","volume":"162","author":"Brunner","year":"1999","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8+ T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1074-7613(01)00259-X","article-title":"Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength","volume":"16","author":"Egen","year":"2002","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2010.09.006","article-title":"Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation","volume":"33","author":"Yokosuka","year":"2010","journal-title":"Immunity"},{"key":"B101","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1242\/jcs.042762","article-title":"The T-cell-receptor signaling network","volume":"122","author":"Huse","year":"2009","journal-title":"J Cell Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/(sici)1096-9896(199710)183:2182:aid-path9183.0.co;2-i","article-title":"In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas","volume":"183","author":"Xerri","year":"1997","journal-title":"J Pathol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6446","DOI":"10.1158\/1078-0432.ccr-09-1339","article-title":"Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma","volume":"15","author":"Ansell","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1182\/blood-2008-07-168468","article-title":"CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation","volume":"113","author":"Bashey","year":"2009","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3109\/10428194.2013.820294","article-title":"Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study","volume":"55","author":"Khorshied","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1172\/jci67008","article-title":"PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells","volume":"123","author":"West","year":"2013","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1158\/0008-5472.can-05-4303","article-title":"Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up","volume":"66","author":"Thompson","year":"2006","journal-title":"Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1158\/1078-0432.ccr-04-1469","article-title":"Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer","volume":"11","author":"Ohigashi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/leu.2014.137","article-title":"High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial","volume":"28","author":"Rossille","year":"2014","journal-title":"Leukemia"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3324\/haematol.2012.071340","article-title":"Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells","volume":"98","author":"Wang","year":"2013","journal-title":"Haematologica"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1182\/blood-2009-03-206672","article-title":"PD-1\/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model","volume":"114","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J Exp Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"17765","DOI":"10.1073\/pnas.0708767104","article-title":"Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability","volume":"104","author":"Pentcheva-Hoang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","article-title":"Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer","volume":"120","author":"Ramsay","year":"2012","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1200\/jco.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J Clin Oncol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1158\/1078-0432.ccr-07-4079","article-title":"Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies","volume":"14","author":"Berger","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1200\/jco.2012.48.3685","article-title":"Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial","volume":"31","author":"Armand","year":"2013","journal-title":"J Clin Oncol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s1470-2045(13)70551-5","article-title":"Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial","volume":"15","author":"Westin","year":"2014","journal-title":"Lancet Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s1470-2045(13)70587-4","article-title":"Anti-PD1 antibody: a new approach to treatment of lymphomas","volume":"15","author":"Bachy","year":"2014","journal-title":"Lancet Oncol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1182\/blood-2012-08-448332","article-title":"Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide","volume":"121","author":"Ramsay","year":"2013","journal-title":"Blood"},{"key":"B130","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.immuni.2007.12.016","article-title":"Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory","volume":"28","author":"Scholer","year":"2008","journal-title":"Immunity"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1182\/blood-2008-10-185280","article-title":"Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a \u00e2\u20ac\u0153vaccinal effect\u00e2\u20ac\u009d of rituximab","volume":"113","author":"Hilchey","year":"2009","journal-title":"Blood"},{"key":"B132","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.immuni.2008.03.012","article-title":"Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor","volume":"28","author":"Teague","year":"2008","journal-title":"Immunity"},{"key":"B133","doi-asserted-by":"publisher","first-page":"805","DOI":"10.4049\/jimmunol.1003314","article-title":"Impairment of immunological synapse formation in adaptively tolerant T cells","volume":"187","author":"Choi","year":"2011","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1182\/blood-2005-03-0996","article-title":"Secretion of IFN-gamma and not IL-2 by anergic human T cells correlates with assembly of an immature immune synapse","volume":"106","author":"Carlin","year":"2005","journal-title":"Blood"},{"key":"B135","doi-asserted-by":"publisher","first-page":"829","DOI":"10.4049\/jimmunol.175.2.829","article-title":"Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation","volume":"175","author":"Ise","year":"2005","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/j.1600-6143.2006.01517.x","article-title":"In vivo anergized T cells form altered immunological synapses in vitro","volume":"6","author":"Zambricki","year":"2006","journal-title":"Am J Transplant"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.4049\/jimmunol.0902285","article-title":"Anergic CD4+ T cells form mature immunological synapses with enhanced accumulation of c-Cbl and Cbl-b","volume":"184","author":"Doherty","year":"2010","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.4049\/jimmunol.169.4.1705","article-title":"TCR\/CD3 down-modulation and zeta degradation are regulated by ZAP-70","volume":"169","author":"Dumont","year":"2002","journal-title":"J Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.immuni.2009.08.024","article-title":"The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse","volume":"31","author":"Jenkins","year":"2009","journal-title":"Immunity"},{"key":"B140","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.imlet.2003.11.022","article-title":"Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation","volume":"92","author":"Gombos","year":"2004","journal-title":"Immunol Lett"},{"key":"B141","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/77842","article-title":"Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation","volume":"1","author":"Anderson","year":"2000","journal-title":"Nat Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.4049\/jimmunol.170.3.1329","article-title":"MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse","volume":"170","author":"Hiltbold","year":"2003","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T01:42:08Z","timestamp":1691718128000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fimmu.2015.00258\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":142,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2015.00258","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}